Int. J. Mol. Sci. 2014, 15(5), 7352-7379; doi:10.3390/ijms15057352
Review

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)

* email, email and email
Received: 1 March 2014; in revised form: 28 March 2014 / Accepted: 10 April 2014 / Published: 29 April 2014
(This article belongs to the collection Molecular Mechanisms of Human Liver Diseases)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), in which most patients exhibit non-progressive, non-alcoholic fatty liver (NAFL) attributable to simple steatosis. Multiple hits, including genetic differences, fat accumulation, insulin resistance and intestinal microbiota changes, account for the progression of NASH. NAFLD is strongly associated with obesity, which induces adipokine secretion, endoplasmic reticulum (ER) and oxidative stress at the cellular level, which in turn induces hepatic steatosis, inflammation and fibrosis. Among these factors, gut microbiota are acknowledged as having an important role in initiating this multifactorial disease. Oxidative stress is considered to be a key contributor in the progression from NAFL to NASH. Macrophage infiltration is apparent in NAFL and NASH, while T-cell infiltration is apparent in NASH. Although several clinical trials have shown that antioxidative therapy with vitamin E can effectively control hepatitis pathology in the short term, the long-term effects remain obscure and have often proved to be ineffective in many other diseases. Several long-term antioxidant protocols have failed to reduce mortality. New treatment modalities that incorporate current understanding of NAFLD molecular pathogenesis must be considered.
Keywords: non-alcoholic fatty liver; non-alcoholic steatohepatitis; microbiome; oxidative stress
PDF Full-text Download PDF Full-Text [3081 KB, Updated Version, uploaded 19 June 2014 05:39 CEST]
The original version is still available [3068 KB, uploaded 19 June 2014 05:39 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Takaki, A.; Kawai, D.; Yamamoto, K. Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH). Int. J. Mol. Sci. 2014, 15, 7352-7379.

AMA Style

Takaki A, Kawai D, Yamamoto K. Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences. 2014; 15(5):7352-7379.

Chicago/Turabian Style

Takaki, Akinobu; Kawai, Daisuke; Yamamoto, Kazuhide. 2014. "Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)." Int. J. Mol. Sci. 15, no. 5: 7352-7379.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert